Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism.
about
11q deletion in neuroblastoma: a review of biological and clinical implications.Research progress of neuroblastoma related gene variations.TIAM1 variants improve clinical outcome in neuroblastoma.Loss of DNA Damage Response in Neuroblastoma and Utility of a PARP Inhibitor.Neuroblastoma Cell Lines Are Refractory to Genotoxic Drug-Mediated Induction of Ligands for NK Cell-Activating Receptors.
P2860
Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Ataxia-telangiectasia mutated ...... a MYCN independent mechanism.
@ast
Ataxia-telangiectasia mutated ...... a MYCN independent mechanism.
@en
type
label
Ataxia-telangiectasia mutated ...... a MYCN independent mechanism.
@ast
Ataxia-telangiectasia mutated ...... a MYCN independent mechanism.
@en
prefLabel
Ataxia-telangiectasia mutated ...... a MYCN independent mechanism.
@ast
Ataxia-telangiectasia mutated ...... a MYCN independent mechanism.
@en
P2093
P2860
P50
P356
P1433
P1476
Ataxia-telangiectasia mutated ...... h a MYCN independent mechanism
@en
P2093
David R Betts
Denis Marino
Edward F Attiyeh
Fabienne Gumy-Pause
Jan J Molenaar
John M Maris
Laurence Lesne
Linda J Valentijn
Marc Ansari
Mary Boudal-Khoshbeen
P2860
P304
18558-18576
P356
10.18632/ONCOTARGET.4061
P407
P577
2015-07-01T00:00:00Z